Clinical trial

A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of…

NCT00145769 · Trans Tasman Radiation Oncology Group, Other · Completed

Key facts

NCT number NCT00145769
Title A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum
Official title A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum
Lead sponsor Trans Tasman Radiation Oncology Group, Other
Collaborators Australasian Gastro-Intestinal Trials Group Colorectal Surgical Society of Australasia (CSSA) Royal Australasian College of Surgeons (RACS)
Status Completed
Phase Phase 3
Study type Interventional
Conditions Adenocarcinoma of Rectum
Intervention type Drug, Procedure, Radiation
Interventions Short Course Adjuvent Chemotherapy, Long Course Adjuvant Chemotherapy, Short Course Radiotherapy, Long Course Radiotherapy, Concurrent Chemotherapy, Initial Surgery
Enrollment 326
Start date Jul 1, 2001
Primary completion Jun 1, 2009
Completion May 1, 2011
First posted Sep 5, 2005
Last update posted Aug 9, 2013
Countries Australia, New Zealand

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies